Development of an optimized procedure for the preparation of rat intestinal microsomes: Comparison of hepatic and intestinal microsomal cytochrome P450 enzyme activities in two rat strains

Xenobiotica

Volumn 39, Issue 1, 2009, Pages 22-32

  Bruyere A ^a,b   Decleves X ^b   Bouzom, F ^a   Proust, L ^a   Martinet, M ^a   Walther, B ^a   Parmentier, Y ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b INSERM   (France)

Author keywords

Cytochromes P450; Intestine; Microsome; Preparation; Rat

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2B1; CYTOCHROME P450 2C11; CYTOCHROME P450 2C6; CYTOCHROME P450 2D2; CYTOCHROME P450 3A; CYTOCHROME P450 3A2; DICLOFENAC; ETHOXYRESORUFIN; MIDAZOLAM; PENTOXYRESORUFIN; PROPRANOLOL; RECOMBINANT ENZYME; TESTOSTERONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE; INTESTINE CELL; LIVER MICROSOME; MALE; MICROSOME; MOLECULAR PROBE; NONHUMAN; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; SPRAGUE DAWLEY RAT; WISTAR RAT;

ANIMALS; CELL FRACTIONATION; CYTOCHROME P-450 ENZYME SYSTEM; INTESTINES; LIVER; MALE; MICROSOMES; MICROSOMES, LIVER; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY;

RATTUS;

EID: 61649118149     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.1080/00498250802517714     Document Type: Article

References (32)

1. Arlotto MP, Trant JM, Estabook RW. 1991. Measurement of steroid hydroxylation by high performance liquid chromatography as indicator of P450 identity and function. Methods in Enzymology 206:454-462.
2. Burke MD, Thompson S, Weaver RJ, Wolf CR, Mayer RT. 1994. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochemical Pharmacology 48:923-936.
3. Caron E, Rioux N, Nicolas O, Lebel-Talbot H, Hamelin BA. 2005. Quantification of the expression and inducibility of 12 rat cytochromes P450 isoforms by quantitative RT-PCR. Journal of Biochemical and Molecular Toxicology 19:368-378.
4. Chung WG, Roh HK, Kim HR, Cha YN. 1998. Involvement of CYP3A1, 2B1, and 2E1 in C-8 hydroxylation and CYP 1A2 and flavin-containing monooxygenase in N-demethylation of caffeine; identified by using inducer treated rat liver microsomes that are characterized with TESTO metabolic patterns. Chemical-Biological Interactions 113:1-14.
5. Debersac P, Heidel JM, Amoit MJ, Goudonnet H, Artur Y, Suschetet M, Siess MH. 2001. Induction of cytochrome P450 and/or detoxication enzymes by various extracts of rosemary: description of specific patterns. Food and Chemical Toxicology 39:907-918.
6. Dhawan A, Parmar D, Dayal M, Seth PK. 1999. Cytochrome P450 isoenzyme specific dealkyltion of alkoxyresorufins in rat brain microsomes. Molecular and Cellular Biochemistry 200:169-176.
7. Doherty MM, Charmann WN. 2002. The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism? Clinical Pharmacokinetics 41:235-253.
8. Fasco MJ, Silkworth JB, Dunbar DA, Kaminsky LS. 1993. Rat small intestinal cytochromes P450 probed by warfarin metabolism. Molecular Pharmacology 43:226-233.
9. Hiroi T, Chow T, Imaoka S. 2002. Catalytic specificity of CYP isoforms in rat and human. Drug Metabolism and Disposition 30:970-976.
10. Huang DY, Ohnishi T, Jiang H, Furukawa A, Ichikawa Y. 1999. Inhibition by retinoids of benzo(-)pyrene metabolism catalysed by 3-methylcholanthrene- induced rat cytochrome P450 1A1. Metabolism 48:689-692.
11. Iwersen S, Schmoldt A. 1997. A specific hydroxysteroid UGT is responsible for the conjugation of aliphatic alcohols in rat: an estimation of the importance of glucuronidation versus oxidation. Alcohol 15:185-192.
12. Kenworthy KE, Bloomer JC, Clarke SE, Houston JB. 1999. CYP3A4 drug interactions: correlation of 10 in vitro probe substrates. British Journal of Clinical Pharmacology 48:716-727.
13. Kobayashi K, Urashima K, Shimada N, Chiba K. 2002. Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat. Biochemical Pharmacology 63:889-896.
14. Komura H, Yasuda M, Yoshida NH, Sugiyama Y. 2002. Species difference in nisoldipine oxidation activity in the small intestine. Drug Metabolism and Pharmacokinetics 17:427-436.
15. Lindell M, Lang M, Lennernäs H. 2003. Expression of genes encoding for drug metabolising cytochrome P450 enzymes and P-glycoprotein in the rat small intestine, comparison to the liver. European Journal of Drug Metabolism and Pharmacokinetics 28:41-48.
16. Lu C, Li P, Gallegos R, Uttamsingh V, Xia CQ, Miw GT, Balani SK, Gan LS. 2006. Comparison of intrinsic clearance in liver microsomes and hepatocytes from rat and humans: evaluation of free fraction and uptake in hepatocytes. Drug Metabolism and Disposition 34:1600-1605.
17. Matsubara T, Koike M, Touchi A, Tochino Y, Sugeno K. 1976. Quantitative determination of cytochrome P450 in rat liver homogenates. Analytical Biochemistry 75:596-603.
18. Mitschke D, Reichel A, Fricker G, Moenning U. 2008. Characterization of cytochrome P450 protein expression along the entire length of the intestine of male and female rats. Drug Metabolism and Disposition 36:1039-1045.
19. Mohri K, Uesawa Y. 2001. Enzymatic activities in the microsomes prepared from rat small intestinal epithelial cells by differential procedures. Pharmaceutical Research 18:1232-1236.
20. Murray M. 1992. Metabolite intermediate complexation of microsomal cytochrome P450 2C11 in male rat liver by nortriptyline. Molecular Pharmacology 42:931-938.
21. Omura T, Sato R. 1964. The carbon monoxyde-binding pigment of liver microsomes. Journal of Biological Chemistry 239:2370-2378.
22. Paine MF, Shen DD, Kunze KL, Perkins JD, Marsh CL, McVicar JP, Barr DM, Gillies BS, Thummel KE. 1996. First-pass metabolism of MDZ by the human intestine. Clinical Pharmacology and Therapeutics 60:14-24.
23. Saito K, Sakai N, Kim HS, Ishizuka M, Kazusaka A, Fujita S. 2004. Strain differences in diazepam metabolism at its three metabolic sites in Sprague-Dawley, Brown Norway, Dark Agouti and Wistar strain rats. Drug Metabolism and Disposition 32:959-965.
24. Sesardic D, Boobis AR, Muray BP, Murray S, Segura J, De le Torre R, Davies DS. 1990. Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man. British Journal of Clinical Pharmacology 29:651-663.
25. Spatzenegger M, Horsmans Y, Verbeeck RK. 2000. Differential activities of CYP1A isozymes in hepatic and intestinal microsomes of control and 3-methylcholanthrene-induced rats. Pharmacology and Toxicology 86:71-77.
26. Takemoto K, Yamazaki H, Tanaka Y, Nanakajima M, Yokoi T. 2003. Catalytic activities of cytochrome P450 enzymes and UDP-glucuronosyltransfrases involved in drug metabolism in rat everted sacs and intestinal microsomes. Xenobiotica 33:43-55.
27. Van de Kerkhoff E, De Graaf I, De Jager M, Meijer D, Groothuis G. 2005. Characterisation of rat small intestinal and colon precision-cut slices as an in vitro system for drug metabolism and induction studies. Drug Metabolism and Disposition 33:1613-1620.
28. Venkatakrishnan K, Von Moltke LL, Obach RS, Greenblatt DJ. 2003. Drug metabolism and drug interactions: application and clinical value of in vitro models. Current Drug Metabolism 4:423-459.
29. Weaver RJ, Thompson S, Smith G, Dickins M, Elcombe CR, Mayer RT, Burke MD. 1994. A comparative study of constitutive and induced alkoxyresorufine O-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes. Biochemical Pharmacology 47:763-773.
30. Zelding DC, Foley J, Goldsworthy SM, Cook ME, Boyle JE, Ma J, Moomaw CR, Tomer KB, Steenbergen C, Wu S. 1997. CYP2J subfamily cytochrome P450s in the gastrointestinal tract: expression, localization and potential functional significance. Molecular Pharmacology 51:931-943.
31. Zhang QY, Ding X, Dunbar D, Cao L, Kaminsky LS. 1999. Induction of rat intestinal cytochrome P450 2J4. Drug Metabolism and Disposition 27:1123-1127.
32. Zhang QY, Wikoff J, Dunbar D, Kaminsky L. 1996. Characterization of rat small intestinal cytochrome P450 composition and inducibility. Drug Metabolism and Disposition 24:322-328.